Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Price : 16.64 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 16.62 | 16.78 | 16.40 | 16.64 | 6186.00 |
| Oct 22, 2026 | 16.20 | 16.41 | 16.20 | 16.40 | 5523.00 |
| Oct 21, 2026 | 16.37 | 16.62 | 16.16 | 16.22 | 13641.00 |
| Oct 20, 2026 | 16.48 | 16.48 | 16.36 | 16.38 | 102640.0 |
| Oct 19, 2026 | 16.40 | 16.43 | 16.20 | 16.35 | 8082.00 |
| Oct 16, 2026 | 16.70 | 16.70 | 16.20 | 16.28 | 37142.00 |
| Oct 15, 2026 | 16.88 | 16.88 | 16.62 | 16.78 | 3151.00 |
| Oct 14, 2026 | 16.79 | 16.91 | 16.74 | 16.90 | 5254.00 |
| Oct 13, 2026 | 16.72 | 16.91 | 16.69 | 16.72 | 5186.00 |
| Oct 12, 2026 | 16.88 | 17.08 | 16.75 | 16.79 | 5976.00 |
| Oct 09, 2026 | 17.05 | 17.22 | 16.95 | 17.02 | 6942.00 |
| Oct 08, 2026 | 16.75 | 17.04 | 16.75 | 16.99 | 7880.00 |
| Oct 07, 2026 | 16.91 | 17.04 | 16.80 | 16.93 | 7461.00 |
| Oct 06, 2026 | 16.87 | 17.08 | 16.80 | 17.08 | 1858.00 |
| Oct 05, 2026 | 16.98 | 17.12 | 16.82 | 16.90 | 4632.00 |
| Oct 02, 2026 | 16.69 | 17.22 | 16.69 | 17.08 | 7853.00 |
| Oct 01, 2026 | 17.16 | 17.16 | 16.76 | 16.76 | 7081.00 |
| Sep 30, 2026 | 17.24 | 17.24 | 16.92 | 17.20 | 5965.00 |
| Sep 29, 2026 | 16.90 | 17.24 | 16.61 | 17.22 | 16685.00 |
| Sep 28, 2026 | 16.55 | 17.05 | 16.55 | 17.05 | 16070.00 |
| Sep 25, 2026 | 16.80 | 17.07 | 16.62 | 16.62 | 7026.00 |
| Sep 24, 2026 | 16.74 | 16.75 | 16.61 | 16.61 | 6843.00 |
| Sep 23, 2026 | 16.66 | 16.86 | 16.61 | 16.86 | 5340.00 |
| Sep 22, 2026 | 16.85 | 17.11 | 16.72 | 16.92 | 7620.00 |
| Sep 21, 2026 | 17.14 | 17.14 | 16.61 | 16.93 | 7915.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| PE Ratio | 2.130 |
| PS Ratio | 144.26 |
| Price to Book Value | 0.9345 |
| Price to Free Cash Flow | 3.489 |
| Earnings Yield | 46.95% |
| Market Cap | 88.31M |
| Normalized PE Ratio | 6.713 |